By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Poxel SAS 

200 avenue Jean Jaures

Lyon    69007  France
Phone: 33-4-37-372010 Fax: 33-4-37-708815



Company News
Poxel SAS Announces Appointment Of Anne Renevot As Chief Financial Officer 4/25/2017 6:55:32 AM
Poxel SAS Reports Results For Fiscal Year 2016 And Provides Corporate Update 4/3/2017 12:25:59 PM
Poxel SAS To Present New Imeglimin Data At The 9th Scientific Meeting Of The Asian Association For The Study Of Diabetes In Japan 4/3/2017 11:56:48 AM
Poxel SAS Announces Positive Results For Thorough QT Safety Clinical Study Of Imeglimin 3/21/2017 6:53:41 AM
Poxel SAS Announces Appointment Of Christophe Arbet-Engels, MD, PhD, MBA, As Chief Medical Officer And EVP Late Development & Medical Affairs, Based In Boston 3/7/2017 8:28:15 AM
Poxel SAS Announces Fourth Quarter 2016 Financial Update 1/27/2017 8:21:47 AM
Poxel SAS Announces CFO Departure 12/22/2016 1:44:07 PM
Poxel SAS Announces Phase 1 Initiation Of EYP001 For The Treatment Of Chronic Hepatitis B Virus Infection By Licensing Partner Enyo Pharma 12/19/2016 11:46:03 AM
Poxel SAS Release: Ability To Delay Type 2 Diabetes Disease Progression By Preserving Beta Cell Mass Observed In New Imeglimin Data 12/5/2016 1:01:54 PM
Poxel SAS Presents New Data On Imeglimin And PXL770 At The European Association For The Study Of Diabetes Annual Meeting 9/15/2016 11:37:20 AM